Antidepressant trial for pancreatic cancer patients falls short
Symptom relief
Terminated
This study looked at whether the antidepressant escitalopram could reduce depression in people with localized pancreatic cancer who were receiving chemotherapy before surgery. Only 4 people enrolled before the study was stopped early. The goal was to measure changes in depression…
Phase: PHASE2 • Sponsor: Case Comprehensive Cancer Center • Aim: Symptom relief
Last updated May 17, 2026 03:09 UTC